NO20070952L - Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike - Google Patents

Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike

Info

Publication number
NO20070952L
NO20070952L NO20070952A NO20070952A NO20070952L NO 20070952 L NO20070952 L NO 20070952L NO 20070952 A NO20070952 A NO 20070952A NO 20070952 A NO20070952 A NO 20070952A NO 20070952 L NO20070952 L NO 20070952L
Authority
NO
Norway
Prior art keywords
hydroxamic acid
suberoylanilide hydroxamic
formulations
processes
preparation
Prior art date
Application number
NO20070952A
Other languages
English (en)
Inventor
Jeannie Chow Wong
Aaron S Cote
Erik A Dienemann
Kimberly Gallagher
Craig Ikeda
Justin Moser
Pavol Rajniak
Robert A Reed
Cindy Starbuck
Hsien-Hsin Tung
Qingxi Wang
Benjamin Max Cohen
Vincent R Capodanno
Brian Sell
Thomas A Miller
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/018795 external-priority patent/WO2006127321A2/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO20070952L publication Critical patent/NO20070952L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Farmasøytisk preparat eller krystallinsk blanding som har en spesifikk oppløsningsprofil, omfattende suberoylanilidhydroksaminsyre eller et farmasøytisk akseptabelt salt eller hydrat av denne, som en aktiv ingrediens. Det beskrives også en fremgangmåte for fremstilling av den krystallinske blanding eller det farmasøytiske preparat. Oppfinnelsen angår også blandinger med en spesifikk partikkelstørrelsesfordeling.
NO20070952A 2005-05-20 2007-02-20 Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike NO20070952L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68287505P 2005-05-20 2005-05-20
PCT/US2006/018795 WO2006127321A2 (en) 2005-05-20 2006-05-16 Formulations of suberoylanilide hydroxamic acid and methods for producing same

Publications (1)

Publication Number Publication Date
NO20070952L true NO20070952L (no) 2007-03-20

Family

ID=37946173

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070952A NO20070952L (no) 2005-05-20 2007-02-20 Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike

Country Status (7)

Country Link
EP (1) EP2229941A1 (no)
CN (1) CN101080223B (no)
AR (1) AR095159A2 (no)
NO (1) NO20070952L (no)
RU (1) RU2354362C2 (no)
UA (1) UA93355C2 (no)
ZA (1) ZA200700636B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2349985A2 (en) 2008-10-15 2011-08-03 Generics [UK] Limited Process for the preparation of vorinostat
CA2744448A1 (en) * 2008-11-26 2010-06-03 Vinayak Gore Polymorphs
CN102344392B (zh) * 2010-08-03 2015-05-27 杭州容立医药科技有限公司 一种蛋白脱乙酰酶抑制剂伏立诺他的精制方法
CN102643214B (zh) * 2011-02-21 2016-08-03 杭州容立医药科技有限公司 伏立诺他ⅰ晶形大晶粒的制备方法及制剂
CN103159646B (zh) * 2013-03-19 2014-10-22 广东药学院 一种异羟肟酸类化合物及其制备方法和应用
CN107362148B (zh) * 2017-07-27 2020-04-21 东曜药业有限公司 一种治疗肿瘤的药物组合物及其制备方法和应用
CN108929246B (zh) * 2018-07-09 2021-07-02 湖南中医药大学 一种固态法制备羟肟酸类衍生物的方法
CN110283102B (zh) * 2019-05-31 2022-09-27 宿州亿帆药业有限公司 一种伏林司他ⅰ晶型的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP2266552A3 (en) * 2002-03-04 2011-03-02 Merck HDAC Research, LLC Methods of inducing terminal differentiation
US7456219B2 (en) * 2002-03-04 2008-11-25 Merck Hdac Research, Llc Polymorphs of suberoylanilide hydroxamic acid

Also Published As

Publication number Publication date
ZA200700636B (en) 2008-10-29
EP2229941A1 (en) 2010-09-22
RU2354362C2 (ru) 2009-05-10
AR095159A2 (es) 2015-09-30
CN101080223A (zh) 2007-11-28
CN101080223B (zh) 2015-02-11
RU2007106072A (ru) 2008-08-27
UA93355C2 (ru) 2011-02-10

Similar Documents

Publication Publication Date Title
NO20070952L (no) Formuleringer av suberoylanilidhydroksaminsyre og fremgangsmate for fremstilling av slike
NO20082124L (no) Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
PH12018500212A1 (en) 1,3,4-oxadiazole sulfonamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
WO2017123884A8 (en) Heterocyclic compounds as rsv inhibitors
NO20090723L (no) Kondenserte heterosykliske derivater og fremgangsmater for anvendelse
WO2012007868A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
NO20073959L (no) Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller
NO20055219L (no) Nye forbindelser
NO20076093L (no) Substituerte amidderivater som proteinkinaseinhibitorer
WO2011003853A3 (en) Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
NZ759512A (en) Delayed release compositions of linaclotide
NO20082673L (no) Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
PH12020550341A1 (en) Niraparib formulations
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
MX336318B (es) Co-cristales de tramadol y nsaids.
NO20082709L (no) Kjemiske forbindelser
NO20076508L (no) Acyloksykarbamat prodroger av traneksaminsyre og fremgangsmater for fremstilling og anvendelse derav
WO2015114395A9 (en) Process for the preparation of vortioxetine salts
BRPI0413186A (pt) composição de fexofenadina e processo para preparação da mesma
MY144613A (en) Formulations of suberoylanilide hydroxamic acid and methods for producing same
MX2022006104A (es) Composicion farmaceutica oral que comprende compuesto de carbamato y metodo de preparacion para la misma.
NO20070665L (no) Derivater av 1-fenylalkankarboksylsyrer for behandlingen av neurodegenerative sykdommer
WO2006050471A3 (en) Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
UA95274C2 (ru) Твердый фармацевтический препарат, содержащий ирбесартан, и способы его изготовления
MX2022004878A (es) Derivados de n-(heteroaril)quinazolin-2-amina a manera de inhibidores de lrrk2, composiciones farmaceuticas y usos de los mismos.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application